Prat A - Search Results

1

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis.

Schettini F, Pascual T, Conte B, Chic N, Brasó-Maristany F, Galván P, Martínez O, Adamo B, Vidal M, Muñoz M, Fernández-Martinez A, Rognoni C, Griguolo G, Guarneri V, Conte PF, Locci M, Brase JC, Gonzalez-Farre B, Villagrasa P, De Placido S, Schiff R, Veeraraghavan J, Rimawi MF, Osborne CK, Pernas S, Perou CM, Carey LA, Prat A. Schettini F, et al. Among authors: prat a. Cancer Treat Rev. 2020 Mar;84:101965. doi: 10.1016/j.ctrv.2020.101965. Epub 2020 Jan 17. Cancer Treat Rev. 2020. PMID: 32000054 Free PMC article.

2

A rare case of malignant solitary fibrous tumor of the spinal cord.

Muñoz E, Prat A, Adamo B, Peralta S, Ramón y Cajal S, Valverde C. Muñoz E, et al. Among authors: prat a. Spine (Phila Pa 1976). 2008 May 20;33(12):E397-9. doi: 10.1097/BRS.0b013e31817343dc. Spine (Phila Pa 1976). 2008. PMID: 18496336 Review.

3

The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Prat A, Baselga J. Prat A, et al. Nat Clin Pract Oncol. 2008 Sep;5(9):531-42. doi: 10.1038/ncponc1179. Epub 2008 Jul 8. Nat Clin Pract Oncol. 2008. PMID: 18607391 Review.

4

Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels.

Prat A, Parera M, Adamo B, Peralta S, Perez-Benavente MA, Garcia A, Gil-Moreno A, Martinez-Palones JM, Baselga J, del Campo JM. Prat A, et al. Ann Oncol. 2009 Feb;20(2):294-7. doi: 10.1093/annonc/mdn601. Epub 2008 Sep 26. Ann Oncol. 2009. PMID: 18820245 Free article.

5

Mammary development meets cancer genomics.

Prat A, Perou CM. Prat A, et al. Nat Med. 2009 Aug;15(8):842-4. doi: 10.1038/nm0809-842. Nat Med. 2009. PMID: 19661985 No abstract available.

6

WITHDRAWN: Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2010 Apr 14. doi: 10.1016/j.molonc.2010.04.003. Online ahead of print. Mol Oncol. 2010. PMID: 20447881 Free article. No abstract available.

7

Clinical implementation of the intrinsic subtypes of breast cancer.

Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS. Perou CM, et al. Among authors: prat a. Lancet Oncol. 2010 Aug;11(8):718-9; author reply 720-1. doi: 10.1016/S1470-2045(10)70176-5. Lancet Oncol. 2010. PMID: 20688274 No abstract available.

8

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Prat A, et al. Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2. Breast Cancer Res. 2010. PMID: 20813035 Free PMC article.

9

Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2011 Feb;5(1):5-23. doi: 10.1016/j.molonc.2010.11.003. Epub 2010 Nov 24. Mol Oncol. 2011. PMID: 21147047 Free PMC article. Review.

10

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.

Fan C, Prat A, Parker JS, Liu Y, Carey LA, Troester MA, Perou CM. Fan C, et al. Among authors: prat a. BMC Med Genomics. 2011 Jan 9;4:3. doi: 10.1186/1755-8794-4-3. BMC Med Genomics. 2011. PMID: 21214954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

905 results

Search Page